Editas Medicine, Inc.
EDIT
$2.90
-$0.03-1.02%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 38.69M | 40.52M | 46.38M | 38.90M | 35.84M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 38.69M | 40.52M | 46.38M | 38.90M | 35.84M |
| Cost of Revenue | 80.96M | 89.95M | 111.16M | 139.02M | 177.05M |
| Gross Profit | -42.27M | -49.43M | -64.78M | -100.12M | -141.22M |
| SG&A Expenses | 46.76M | 49.90M | 54.90M | 60.68M | 66.02M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 127.72M | 139.86M | 166.06M | 199.70M | 243.08M |
| Operating Income | -89.03M | -99.34M | -119.68M | -160.80M | -207.24M |
| Income Before Tax | -108.95M | -160.06M | -199.84M | -236.86M | -251.23M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -108.95 | -160.06 | -199.84 | -236.86 | -251.23 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -108.95M | -160.06M | -199.84M | -236.86M | -251.23M |
| EBIT | -89.03M | -99.34M | -119.68M | -160.80M | -207.24M |
| EBITDA | -85.19M | -94.06M | -112.04M | -152.28M | -199.13M |
| EPS Basic | -1.22 | -1.88 | -2.38 | -2.85 | -3.04 |
| Normalized Basic EPS | -0.60 | -0.71 | -0.90 | -1.19 | -1.50 |
| EPS Diluted | -1.22 | -1.88 | -2.38 | -2.85 | -3.04 |
| Normalized Diluted EPS | -0.60 | -0.71 | -0.90 | -1.19 | -1.50 |
| Average Basic Shares Outstanding | 369.64M | 354.81M | 340.17M | 332.57M | 330.46M |
| Average Diluted Shares Outstanding | 369.64M | 354.81M | 340.17M | 332.57M | 330.46M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |